Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 4:15 AM ET

Biotechnology

Company Overview of BioCardia, Inc.

Executive Profile

Peter A. Altman Ph.D.

Chief Executive Officer, President and Director, BioCardia, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
49$864,415
As of Fiscal Year 2014

Background

Dr. Peter A. Altman PhD has been Chief Executive Officer and President of BioCardia, Inc. since 1999. Dr. Altman served as an acting Chief Executive Officer of Lumen Therapeutics from 2004 to 2005. He served as Founding Chief Executive Officer of Expression Diagnostics, Inc., from 2000 to 2003. Dr. Altman served as founding President and Chief Executive Officer for XDx, Inc. from 1998 to 2003. He was also an inventor of the technology that is being developed by medical ...

Corporate Headquarters

125 Shoreway Road
San Carlos, California 94070

United States

Phone: 650-226-0120
Fax: 650-631-3731

Board Members Memberships

Chief Executive Officer, President and Director

Education

MS
Columbia University
BS
Columbia University
PhD
University of California Berkeley
PhD
University of California-San Francisco
MS
The Fu Foundation School of Engineering & Applied Science
BS
The Fu Foundation School of Engineering & Applied Science

Other Affiliations

Annual Compensation

Salary$205,800
Bonus$41,160
Total Annual Compensation$246,960

Stocks Options

Exercisable Options$73,336
Unexercisable Options$176,290
Total Number of Options$249,626

Total Compensation

Total Annual Cash Compensation$246,960
Total Short Term Compensation$246,960
Total Calculated Compensation$864,415
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioCardia, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.